Global Infusion Pump Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2024

Published - Apr 2019 | Category - Pharma & Healthcare | No. of Pages - 139 | Published By - EMR

Global Infusion Pump Market is expected to grow significantly from USD 9,210 million in 2017 to USD 14,500 million in 2024, at a thriving CAGR of 6.6% from 2018 to 2024.

The major growth driver in the global infusion pump market is the growing incidence of chronic diseases, and increasing number of surgical procedure performed across the globe. Moreover, rising demand in the ambulatory settings, owing to growing number of surgical procedure performed in also driving the market growth. Additionally, growing prevalence of diabetes across the globe, as well as increasing awareness towards insulin delivering devices is also augmenting the growth of the infusion pump market.

Infusion pump is a medical device that is capable of delivering nutrients, antibiotics, insulin, chemotherapy or pain relief drugs and other medications into the patient’s body in a controlled amount. Approximately, millions of infusion pumps are used around the world in various end-user segments such as home setting, hospital, clinics, laboratory, and ambulatory surgical centers. The infusion pump plays the important role in providing preoperative care, critical care, and pain management.

Global Infusion Pump Market Major Key Companies

Fresenius SE & Co. KGaA
B. Braun Melsungen AG
Baxter International Inc.
Medical International Limited
Terumo Corporation
F. Hoffmann-La Roche Ltd.
Johnson & Johnson
Dickinson and Company
ICU Medical, Inc.


Quick Buy

Latest Publications